纳米载体在胃癌淋巴靶向化疗中的应用研究  

Applications of nanoparticle carriers used in lymph-targeted chemotherapy for gastric carcinoma

作　　者：张兴源[1] 蔡元坤[1] 

机构地区：[1]复旦大学附属上海市第五人民医院普外科,上海200240

出　　处：《国际外科学杂志》2010年第8期544-548,共5页International Journal of Surgery

摘　　要：纳米载体的出现,彻底改变了胃癌及其他肿瘤的传统治疗模式,使化疗药物在体内的分布更合理,靶向性更强,不良反应更轻,并且能对抗肿瘤细胞的耐药机制.在胃癌淋巴靶向化疗中应用纳米载体,不仅能够获得更好的疗效,还能指导手术,改进患者的生活质量,具有广阔的应用前景.The occurrence of nanoparticle carriers has greatly changed the traditional remedies of gastric cancer and other malignant tumors which makes the chemotherapeutic drugs possess better distribution, better targeting, less side-effects, and the ability to withstand the drug-resistance of tumor cells. Utilization of nanoparticle carriers in lymph-targeted chemotherapy of gastric cancer can not only achieve a better curative effect,but also direct the operation and improve patients＇ quality of lives. It has an expansive application foreground.

关 键 词：纳米载体 胃癌 淋巴靶向化疗 纳米活性炭 

分 类 号：R735.2[医药卫生—肿瘤]